FDA Inspection 1040602 — Enem Nostrum Remedies Pvt. Ltd
The FDA completed an inspection of Enem Nostrum Remedies Pvt. Ltd on January 31, 2018 in Mumbai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 31, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mumbai (India)
Additional Details
In Vivo Bioequivalence